Bruker Corporation

The current price of BRKR is $58.06 — it has decreased by 8.98% since the previous close. Data as of Nov 5, 2026.

BRKR is down 3.23% over the past week, down 4.03% over the past month and up 47.70% over the past year. The price is above its 200-day moving average of $50.36.

Analysts' average 12-month price target for BRKR is $67.00, which implies 15.40% upside from the current price. Individual estimates range from $50.00 to $80.00.

Of the 13 analysts covering Bruker Corporation, 1 rates it a strong buy, 5 rate it a buy, 6 rate it a hold and 1 rates it a sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Bruker Corporation has a market capitalization of $8.85B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Bruker Corporation posted earnings of $0.56 per share against an estimate of $0.419, beating expectations by 33.65%. Upcoming reports are listed in the earnings calendar.

Bruker Corporation reported revenue of $874M in its most recent quarter, which has increased by 1.57% compared with the same quarter a year earlier. Analysts had expected $865.16M.

Yes. Bruker Corporation pays dividends quarterly. The latest payment of $0.05 per share has a payment date of Oct 7, 2026, which corresponds to a dividend yield of 0.32%.

Companies most comparable to Bruker Corporation include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Waters Corporation and Mettler-Toledo International Inc.

In the latest trading session BRKR moved between $57.87 and $62.33, a range of 7.68% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Bruker Corporation shows a sell rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Bruker Corporation is buy. Technical ratings are indicators, not investment advice.

Over the past 52 weeks BRKR has traded between $32.37 and $68.98. The current price is 15.83% below its 52-week high.